1. Home
  2. NVO vs SAP Comparison

NVO vs SAP Comparison

Compare NVO & SAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVO
  • SAP
  • Stock Information
  • Founded
  • NVO 1923
  • SAP 1972
  • Country
  • NVO Denmark
  • SAP Germany
  • Employees
  • NVO N/A
  • SAP N/A
  • Industry
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • SAP Computer Software: Prepackaged Software
  • Sector
  • NVO Health Care
  • SAP Technology
  • Exchange
  • NVO Nasdaq
  • SAP Nasdaq
  • Market Cap
  • NVO 278.0B
  • SAP 302.3B
  • IPO Year
  • NVO N/A
  • SAP 1998
  • Fundamental
  • Price
  • NVO $65.73
  • SAP $293.99
  • Analyst Decision
  • NVO Strong Buy
  • SAP Buy
  • Analyst Count
  • NVO 4
  • SAP 6
  • Target Price
  • NVO $128.00
  • SAP $288.67
  • AVG Volume (30 Days)
  • NVO 11.2M
  • SAP 1.6M
  • Earning Date
  • NVO 05-07-2025
  • SAP 04-22-2025
  • Dividend Yield
  • NVO 2.45%
  • SAP 0.63%
  • EPS Growth
  • NVO 17.93
  • SAP 18.36
  • EPS
  • NVO 3.40
  • SAP 5.24
  • Revenue
  • NVO $43,922,211,349.00
  • SAP $37,989,623,853.00
  • Revenue This Year
  • NVO $20.22
  • SAP $11.99
  • Revenue Next Year
  • NVO $16.10
  • SAP $11.97
  • P/E Ratio
  • NVO $19.32
  • SAP $56.10
  • Revenue Growth
  • NVO 24.11
  • SAP 10.51
  • 52 Week Low
  • NVO $57.00
  • SAP $179.43
  • 52 Week High
  • NVO $148.15
  • SAP $303.40
  • Technical
  • Relative Strength Index (RSI)
  • NVO 48.22
  • SAP 62.05
  • Support Level
  • NVO $64.40
  • SAP $285.79
  • Resistance Level
  • NVO $69.67
  • SAP $303.40
  • Average True Range (ATR)
  • NVO 1.74
  • SAP 4.73
  • MACD
  • NVO 0.85
  • SAP 1.94
  • Stochastic Oscillator
  • NVO 62.20
  • SAP 83.06

About NVO Novo Nordisk A/S

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About SAP SAP SE ADS

Founded in Germany in 1972 by former IBM employees, SAP is the world's largest provider of enterprise application software. Known as the leader in enterprise resource planning software, SAP's portfolio also includes software for supply chain management, procurement, travel and expense management, and customer relationship management, among others. The company operates in more than 180 countries and has more than 400,000 customers, approximately 80% of which are small to medium-size enterprises.

Share on Social Networks: